Report Categories
View AllRecent Articles
View All
Will Quince Therapeutics Qncx Stock Miss Expectations Price At 0.99 Down 3.23 20260402
What makes Templeton TEI a safer bet than newer entrants Underperforming 20260507
Splash SBEV Stock Is It Worth Entering Now Modest Uptick 20260418
FITB Fifth Third Bancorp posts 459 percent Q1 2026 EPS beat sending shares 166 percent higher today
Aptevo APVO Sector Impact Aptevo Therapeutics posts 999 EPS surprise far narrower loss than expected
The valuation impact of Portland POR earnings quality Portland Misses Estimates by 346
What PPI data AH Realty AHRT Investor Concern 20260429
WLDN Willdan Group beats Q1 estimates by 75 yet shares decline 16 despite 205 revenue growth
KTTA Pasithea Therapeutics shares climb 21 percent despite reporting a far wider than expected Q4 2025 per share loss
Interparfums Inc Q1 2026 Earnings EPS Surpasses Estimates Stock Rises
Biogen Q1 2026 Earnings Strong EPS Beat Drives PostMarket Rally
Energy Transfer ET Q1 2026 Earnings EPS Miss Slightly Shares Edge Higher Amid Operational Strength
HTO Q1 2026 Earnings EPS Surpasses Estimates Stock Edges Higher
SWBI Q1 2026 Earnings Earnings per Share Beat Estimates Revenue Details Not Provided